The cannabinoid CBD garners increasingly more national attention with every passing quarter, as products land on mainstream (as opposed to licensed dispensary) store shelves, people buy the products online and the press devotes more coverage to the ins and outs of the hemp- or -cannabis-derived natural compound.

While more and more traditional stores carry lines of CBD products, sales of them thrive, too, in dispensaries, where CBD is combined with THC and other parts of the cannabis plant. High-CBD strains, edibles, vape cartridges, topicals and more are now widely for sale in dispensaries.

People and companies that embrace CBD say...

Here’s how the FDA’s review of epilepsy drug could affect CBD companies

It’s shaping up to be a watershed summer for the cannabis industry with the U.S. Food and Drug Administration poised to approve the first drug made from the plant....

GrowForce Acquires Canadian Licensed Producer WILL Cannabis
GrowForce Acquires WILL Cannabis in Brampton, Ontario New Canadian cannabis platform acquires Ontario facility and ACMPR license TORONTO, April 24, 2018 (GLOBE NEWSWIRE) — GrowForce, a newly-launched Canadian-based cannabis platform, announced today the purchase of WILL Cannabis Group in Brampton, Ontario. WILL is an Authorized Licensed Producer of Cannabis for Medical Purposes through Health Canada, […]...

A lot of slogans come to mind when I think about Nick Kovacevich and Kush Bottles (KB), particularly “You’ve come a long way baby” or “I would rather fight than quit”. But until CBE interviewed him to catch-up after the story we wrote about the upstart cannabis packaging company three years ago   (Torn ACL, Basketball’s loss, Cannabis Industry’s Gain: Kush Bottles…) , I never would thought that a slogan like “Powering the Cannabis Powering The Cannabis Industry: Kush BottlesIndustry” would apply to KB. After having Nick share his and Dallas Imbimbo’s (Nick’s high school friend, fellow founder and board member) vision and foresight in...

Stock-based compensation drives up MassRoots’ red ink to $44M in 2017

Turmoil-plagued marijuana tech company MassRoots suffered a $44.3 million loss in 2017, a large portion of which can be attributed to $22 million in stock-based compensation the company handed out during the year. Losses in 2016 totaled $18 million. The Denver-based company’s annual report, filed Tuesday with the U.S. Securities and Exchange Commission, also revealed the […]...

Organigram Posts Record Net Sales of $3.7 Million in Q2
Organigram Announces Record Q2 Financial Results – Net Income of $1.1 Million Record Net Sales of $3.7 Million for the Quarter and Earnings Per Share (Basic) of $0.009 MONCTON, NB, April 24, 2018 /CNW/ – Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB:OGRMF) (the “Company” or “Organigram”), a leading licensed producer of medical marijuana based in […]...

New Federalism Fund and American Trade Association for Cannabis and Hemp Join Forces to Form New Industry EffortNew Federalism Fund and American Trade Association for Cannabis and Hemp Join Forces to Form New Industry Effort

CBE is excited to announce the partnership of the New Federalism Fund and The American Trade Association for Cannabis and Hemp (ATACH). The below press release lays out the mission of the newly formed group and is intended to push the ball over the line to provide the Cannabis Industry with the tools it needs to level the playing field in the competitive industry environment and to end prohibition once and for all.

PRESS RELEASE

This effort will build the institutional strength of both organizations with a focus on ending federal cannabis prohibition and unifying cannabis industry stakeholders  

DENVER, CO...

Why the US needs federal marijuana reform: Q A with Congressman Tom Garrett

U.S. Rep. Tom Garrett isn’t the most likely congressional member to embrace federal marijuana reform. The first-term Republican is from a state – Virginia – that has yet to legalize medical marijuana, although its laws provide protections for people who use cannabidiol oils for medical conditions. Why did Garrett introduce the “Ending Federal Marijuana Prohibition Act […]...

How FDA Approved Cannabis Products Could Affect CBD Distribution Channels
Last week, GW Pharma (NASDAQ: GWPH) scored a milestone victory, as the thirteen-member panel at the Peripheral and Central Nervous System Drugs Advisory Committee, which met on April 19th to consider the safety and efficacy of Epidiolex, its CBD-based product, and pass along its conclusions to the FDA, gave it a unanimous decision in favor of Epidiolex. The committee, […]...

Chart: US hemp production soars in 2017

Rising acceptance for hemp and CBD – combined with easing regulations at the state level – caused U.S. hemp production to surge in 2017. From 2016 to 2017, the number of acres licensed for hemp cultivation in the top 10 hemp-growing states grew by 140% – while the number of hemp producers doubled over the same […]...